Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.
Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system (CNS) characterized by demyelination through glial cell loss. Current and proposed therapeutic strategies to arrest demyelination and/or promote further remyelination include: (i) modulation of the host...
Saved in:
Main Authors: | Corey Heffernan, Huseyin Sumer, Gilles J Guillemin, Ursula Manuelpillai, Paul J Verma |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/d80d25d58d49422cbb3b596d5b5de789 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
by: Park CK, et al.
Published: (2017) -
Synthetic molecular evolution of hybrid cell penetrating peptides
by: W. Berkeley Kauffman, et al.
Published: (2018) -
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
by: Yu Han Liu, et al.
Published: (2012) -
Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
by: L. He, et al.
Published: (2018) -
Synthesis and study of cell-penetrating peptide-modified gold nanoparticles
by: Boussoufi F, et al.
Published: (2018)